La FTC publicó un informe provisional contundente sobre los PBM. ¿Qué sigue?
About two years ago, the Federal Trade Commission began investigating pharmacy benefit managers and recently released some of its findings, which paint a negative picture of the prescription drug middlemen. The report highlights the dominance of the PBM market by six major companies, leading to high drug costs and struggles for patients and independent pharmacies. … Leer más